Hsu, Yao-Chun http://orcid.org/0000-0001-8984-5103
Huang, Daniel Q. http://orcid.org/0000-0002-5165-5061
Nguyen, Mindie H.
Article History
Accepted: 24 February 2023
First Online: 6 April 2023
Competing interests
: Y.-C.H. has received research support from Gilead Sciences, has served as an advisory board member for Gilead Sciences, and has received payments for lectures from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, and Novartis. D.Q.H. has served as a consultant for Eisai. M.H.N. has received research support from Pfizer, Gilead Sciences, Enanta, Vir Biotech, Glycotests, Exact Science, Helio Health, B. K. Kee Foundation, and the National Cancer Institute and has served as an advisory board member or consultant for Gilead, GSK, Intercept, Novartis, Eisai, Bayer, Exact Science, Laboratory of Advanced Medicine, Spring Bank, and Janssen.